Research Article
The Clinicopathologic Importance of Serum Lactic Dehydrogenase in Patients with Gastric Cancer
Table 3
Univariate and multivariate analyses of prognostic variables in gastric cancer patients.
| Parameters | Univariate analysis | Multivariate analysis | | HR (95% CI) | |
| OS | | | | Age (≥60) | 0.676 | — | 0.800 | Gender | 0.076 | — | 0.226 | SLDH | <0.001* | 2.476 (1.450–4.228) | 0.001* | Tumor size | 0.112 | — | 0.105 | Borrmann type | 0.329 | — | 0.070 | Histological type | 0.561 | — | 0.521 | pT stage | <0.001* | — | 0.322 | pN stage | 0.004* | — | 0.630 | pM stage | <0.001* | 2.157 (1.454–3.201) | <0.001* | pTNM | <0.001* | 1.920 (1.548–2.381) | <0.001* | DFS | | | | Age (≥60) | 0.680 | — | 0.938 | Gender | 0.097 | — | 0.250 | SLDH | <0.001* | 2.209 (1.292–3.778) | 0.004* | Tumor size | 0.785 | — | 0.136 | Borrmann type | 0.381 | — | 0.061 | Histological type | 0.632 | — | 0.475 | pT stage | <0.001* | — | 0.197 | pN stage | 0.002* | — | 0.455 | pM stage | <0.001* | 1.926 (1.306–2.840) | 0.001* | pTNM | <0.001* | 1.880 (1.516–2.330) | <0.001* |
|
|
CI: confidence interval; HR: hazard ratio; OS: overall survival; DFS: disease-free survival; p: pathological. SLDH: serum lactate dehydrogenase. .
|